Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
Clinical trial NCT05270837 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05270837
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2025-01-14
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.